Our achievement
> 50
COMBINATION PRODUCTS LAUNCHED
COMBINATION PRODUCTS LAUNCHED
SHL has been a pioneer and leader in the drug delivery industry, driving innovation in autoinjectors and device development. Yet, at our core, lies our purpose of enabling patients’ independence.
It is the core of our business to build innovative, safe and reliable products to advance patients’ health, wellbeing, and independence, with a resolute ambition to further enhance patient outcomes through pioneering devices by 2030.
PATIENTS ENABLED TO BE INDEPENDENT
As innovation leader we bring the most innovative products and services to advance patient health and wellbeing. To manifest our position, we continuously aim for sustainable growth through our research and development efforts, all while consistently expanding and enhancing our portfolio.
Our autoinjector solutions play a vital role in empowering patients, promoting self-reliance, and alleviating the burden on healthcare providers by freeing up valuable time for doctors and nurses, thereby contributing to the overall resilience of our healthcare system. We are continuously working towards bringing our innovative technologies to new therapeutic areas and markets to expand our positive impact for patients and support healthcare professionals, all within the framework of sustainability.
By 2030, we will significantly reduce GHG emissions, introducing circular principles and reduce waste impact.
By 2030, we will manifest a sustainable business foundation for our people and supply chain.